Research use only. Not for human consumption. 18+ only.

Muscle Growth & Performance / Subcutaneous

Carnosine

Also known as β-Alanyl-L-histidine, L-Carnosine

A dipeptide of beta-alanine and histidine that acts as a buffer against lactic acid accumulation, enhancing muscle endurance and reducing fatigue.

What is Carnosine used for? Research has focused on buffers lactic acid accumulation during exercise; enhances muscle endurance and exercise capacity; reduces fatigue in high-intensity activities.

Compare with other peptides studied formuscle growth,fat loss

Evidence grade BCompoundable

Carnosine injection at a glance

Figures from the published research literature. Research use only.

Dose range
1000-2000 mg
Route
Subcutaneous

How often, when, and the dosing notes are in the dosing reference further down.

Work out your units in the free calculator

Research status

Evidence grade B
Smaller human trials, observational studies, or approved in 30 or more countries.
Compoundable
Legal to compound in the US, and approved in other jurisdictions or with a history of approval.

Research compound

For research purposes only. Not approved for human use. Not medical advice.

Research areas

  • Buffers lactic acid accumulation during exercise
  • Enhances muscle endurance and exercise capacity
  • Reduces fatigue in high-intensity activities
  • Supports muscle carnosine levels
  • May improve anaerobic performance
  • Antioxidant and anti-inflammatory properties

Side effects

EffectHow oftenSeverity
Paresthesia (tingling sensation)Harmless tingling in the face, neck, or extremities, typically occurring 15-30 minutes after beta-alanine ingestion. Resolves within 1-2 hours. Not dangerous and does not indicate toxicity. Can be reduced by splitting doses or taking with food.CommonMild
Gastrointestinal discomfortMild nausea, bloating, or stomach upset may occur, particularly at higher doses or on an empty stomach. Taking carnosine with meals typically resolves this.UncommonMild
HeadacheOccasional mild headache reported in early supplementation. Usually resolves with continued use or dose reduction.RareMild
Flushing or facial rednessTransient facial flushing may occur alongside paresthesia. Not harmful and typically subsides within 1-2 hours.UncommonMild

Dosing reference

Dose scale from the research

Starting
1000 mg
Typical
1500 mg
Upper end
2000 mg
Carnosine dosing reference
ParameterValue
Dose range1000-2000 mg
Frequency, timing and route are for members

Checked October 2026

Research disclaimer. Figures are drawn from published research literature and community logs. They are not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution guide

  • Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution
  • Do not shake the vial vigorously; gentle swirling prevents peptide degradation
  • Discard immediately if the solution appears cloudy, discolored, or contains visible particles
  • Use within 30 days of reconstitution when stored at 2-8°C
  • Do not freeze the reconstituted solution; freezing may denature the peptide
  • Use the PeptideVolt reconstitution calculator for your exact concentration
Work out your exact dose in the free peptide calculator

Molecular and pharmacological data

Molecular weight226.23 g/mol
Half-lifeApproximately 1 hour in plasma; accumulates in muscle tissue over weeks of supplementation
SequenceMembers only

Carnosine is a dipeptide composed of beta-alanine and histidine that functions as an intracellular buffer, reducing the accumulation of hydrogen ions (H+) and lactate during high-intensity exercise. By maintaining muscle pH, carnosine delays fatigue onset and supports sustained muscle force production. It also exhibits antioxidant and anti-glycation properties through its histidine moiety.

Pathways and mechanism detail are for members

Keep a log of your Carnosine research

Free account. No credit card required.

Recent research

All results on PubMed

Source: PubMed / NCBI. Updated daily. Articles are listed for research reference only.

Research citations

5 sources
  • Hipkiss AR, Gaunitz F. (2014). Inhibition of protein glycation by carnosine: relevance to diabetes mellitus and other protein cross-linking diseases. Cellular and Molecular Life Sciences. 71(15):2811-2823. DOI: 10.1007/s00018-014-1617-0

  • PubMed PMID: 23657496 - Everaert et al. (2013). Beta-alanine supplementation increases muscle carnosine content and enhances transient muscle force production in healthy adults.

  • PubMed PMID: 25136264 - Saunders B, Elliott-Sale K, Artioli GG, et al. (2017). β-alanine supplementation to improve exercise capacity and performance: a critical review. Journal of the International Society of Sports Nutrition. 14:42.

  • Boldyrev AA, Aldini G, Derave W. (2013). Physiology and pathophysiology of carnosine. Physiological Reviews. 93(4):1803-1845. DOI: 10.1152/physrev.00039.2012

  • PubMed PMID: 22535713 - Hoffman JR, Ratamess NA, Kang J, et al. (2006). Effect of creatine and beta-alanine supplementation on performance and endocrine responses in strength/power athletes.

All Muscle Growth & Performance peptides

Browse the research library

147 peptide profiles and 59 blend profiles with mechanism summaries, dosing data and reconstitution guides.

View all peptides

Stay updated on Carnosine research

A weekly digest of new peptide research, stack guides and site updates.

Research use only. All content on this page is provided for informational and educational purposes related to scientific research. Carnosine is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.